152 related articles for article (PubMed ID: 32640738)
21. The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer.
Farfán N; Ocarez N; Castellón EA; Mejía N; de Herreros AG; Contreras HR
Sci Rep; 2018 Jul; 8(1):11467. PubMed ID: 30065348
[TBL] [Abstract][Full Text] [Related]
22. Functional Organotypic Cultures of Prostate Tissues: A Relevant Preclinical Model that Preserves Hypoxia Sensitivity and Calcium Signaling.
Figiel S; Pasqualin C; Bery F; Maupoil V; Vandier C; Potier-Cartereau M; Domingo I; Guibon R; Bruyere F; Maheo K; Fromont G
Am J Pathol; 2019 Jun; 189(6):1268-1275. PubMed ID: 30954471
[TBL] [Abstract][Full Text] [Related]
23. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
[TBL] [Abstract][Full Text] [Related]
24. Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases.
Chantôme A; Potier-Cartereau M; Clarysse L; Fromont G; Marionneau-Lambot S; Guéguinou M; Pagès JC; Collin C; Oullier T; Girault A; Arbion F; Haelters JP; Jaffrès PA; Pinault M; Besson P; Joulin V; Bougnoux P; Vandier C
Cancer Res; 2013 Aug; 73(15):4852-61. PubMed ID: 23774210
[TBL] [Abstract][Full Text] [Related]
25. DiGalactosyl-Glycero-Ether Lipid: synthetic approaches and evaluation as SK3 channel inhibitor.
Sevrain CM; Haelters JP; Chantôme A; Couthon-Gourvès H; Gueguinou M; Potier-Cartereau M; Vandier C; Jaffrès PA
Org Biomol Chem; 2013 Jul; 11(27):4479-87. PubMed ID: 23715410
[TBL] [Abstract][Full Text] [Related]
26. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
[TBL] [Abstract][Full Text] [Related]
27. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
28. SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
Hou L; Li Q; Yu Y; Li M; Zhang D
Mol Med Rep; 2016 Feb; 13(2):1681-8. PubMed ID: 26717907
[TBL] [Abstract][Full Text] [Related]
29. ZEB1 promotes prostate cancer proliferation and invasion through ERK1/2 signaling pathway.
Song XF; Chang H; Liang Q; Guo ZF; Wu JW
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4032-4038. PubMed ID: 29028100
[TBL] [Abstract][Full Text] [Related]
30. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
Larsen JE; Nathan V; Osborne JK; Farrow RK; Deb D; Sullivan JP; Dospoy PD; Augustyn A; Hight SK; Sato M; Girard L; Behrens C; Wistuba II; Gazdar AF; Hayward NK; Minna JD
J Clin Invest; 2016 Sep; 126(9):3219-35. PubMed ID: 27500490
[TBL] [Abstract][Full Text] [Related]
31. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
32. The calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer.
Wang T; Li N; Jin L; Qi X; Zhang C; Hua D
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118833. PubMed ID: 32860837
[TBL] [Abstract][Full Text] [Related]
33. ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage.
Song N; Jing W; Li C; Bai M; Cheng Y; Li H; Hou K; Li Y; Wang K; Li Z; Liu Y; Qu X; Che X
Cell Cycle; 2018; 17(5):595-604. PubMed ID: 29157079
[TBL] [Abstract][Full Text] [Related]
34. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription.
Deng SJ; Chen HY; Ye Z; Deng SC; Zhu S; Zeng Z; He C; Liu ML; Huang K; Zhong JX; Xu FY; Li Q; Liu Y; Wang CY; Zhao G
Oncogene; 2018 Nov; 37(44):5811-5828. PubMed ID: 29970904
[TBL] [Abstract][Full Text] [Related]
36. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J
PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751
[TBL] [Abstract][Full Text] [Related]
37. KCNQ1OT1/miR-217/ZEB1 feedback loop facilitates cell migration and epithelial-mesenchymal transition in colorectal cancer.
Bian Y; Gao G; Zhang Q; Qian H; Yu L; Yao N; Qian J; Liu B; Qian X
Cancer Biol Ther; 2019; 20(6):886-896. PubMed ID: 30794031
[TBL] [Abstract][Full Text] [Related]
38. Zeb1 and SK3 Channel Are Up-Regulated in Castration-Resistant Prostate Cancer and Promote Neuroendocrine Differentiation.
Bery F; Cancel M; Guéguinou M; Potier-Cartereau M; Vandier C; Chantôme A; Guibon R; Bruyère F; Fromont G; Mahéo K
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34204608
[TBL] [Abstract][Full Text] [Related]
39. ZEB1 modulates endometrial receptivity through epithelial-mesenchymal transition in endometrial epithelial cells in vitro.
Ran J; Yang HH; Huang HP; Huang HL; Xu Z; Zhang W; Wang ZX
Biochem Biophys Res Commun; 2020 May; 525(3):699-705. PubMed ID: 32139122
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
